Eléments de l'association

	M. A. Sanz	1
	Treatment efficiency	56
	M. A. Sanz *Sauf* Treatment efficiency"	0
	Treatment efficiency *Sauf* M. A. Sanz"	55
	M. A. Sanz Et Treatment efficiency	1
	M. A. Sanz Ou Treatment efficiency	56
	*Corpus*	6045

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
003475	K. Geissler [Autriche] ; J. A. Liu Yin [Royaume-Uni] ; A. Ganser [Allemagne] ; M. A. Sanz [Espagne] ; J. Szer [Australie] ; A. Raghavachar [Allemagne] ; D. Hoelzer [Allemagne] ; C. Martinez [Espagne] ; K. Taylor [Australie] ; L. Kanz [Allemagne] ; L. B. To [Australie] ; E. Archimbaud [France]	Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia: a randomized, placebo-controlled, double-blind safety and efficacy study

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024